Read More
Date: 30-3-2016
474
Date: 27-3-2016
466
Date: 29-3-2016
619
|
Antipseudomonal Penicillins
Agents: piperacillin, mezlocillin, carbenicillin, ticarcillin
None of the penicillins we have discussed thus far offer appreciable activity against Pseudomonas aeruginosa, a common nosocomial pathogen that is often resistant to multiple antibiotics. Enter the antipseudomonal penicillins. These agents are active against Pseudomonas aeruginosa and other more drug-resistant GNRs. However, they are just as susceptible to beta-lactamases as penicillin andampicillin, so they are not antistaphylococcal. Also, strains of GNRs that produce beta-lactamases are resistant to them. They do have activity against streptococci and enterococci.
Spectrum
Good: Pseudomonas aeruginosa, streptococci, enterococci
Moderate: enteric GNRs, Haemophilus
Poor : staphylococci, anaerobes
Adverse Effects
Similar to those of other beta-lactams.
Important Facts
• These drugs retain the Gram-positive activity of penicillin and are active against many streptococci and enterococci.
• Antipseudomonal penicillins can be used by themselves or, more commonly, in combination with a beta-lactamase inhibitor.
• Piperacillin is the most frequently prescribed of these agents. It has stronger antipseudomonal activity than ticarcillin. Carbenicillin may be administered orally, but it does not achieveuseful concentrations for the treatment of anything except UTIs. Mezlocillin is not commonly used.
What They’re Good For
Infections caused by susceptible Pseudomonas or other GNRs. If a Gram-positive organism is susceptible to an antipseudomonal penicillin, it will be susceptible to at least one narrower-spectrum penicillin as well, and the narrower-spectrum drug should generally be used.
Don’t Forget!
These drugs are useful step-down agents in the treatment of infections caused by Pseudomonas aeruginosa. However, they are not good empiric therapeutic choices, because other GNRs that cause nosocomial infections may be resistant to them (such as E. coli). Start with a beta-lactamase-resistant agent, then change your therapy to an antipseudomonal penicillin if susceptibilities allow.
References
Gallagher ,J.C. and MacDougall ,c. (2012). Antibiotics Simplified. Second Edition. Jones & Bartlett Learning, LLC.
|
|
دراسة يابانية لتقليل مخاطر أمراض المواليد منخفضي الوزن
|
|
|
|
|
اكتشاف أكبر مرجان في العالم قبالة سواحل جزر سليمان
|
|
|
|
|
اتحاد كليات الطب الملكية البريطانية يشيد بالمستوى العلمي لطلبة جامعة العميد وبيئتها التعليمية
|
|
|